226 related articles for article (PubMed ID: 19762191)
1. Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis.
Nahon P; Ganne-Carrié N; Trinchet JC; Beaugrand M
Gastroenterol Clin Biol; 2010 Jan; 34(1):1-7. PubMed ID: 19762191
[TBL] [Abstract][Full Text] [Related]
2. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
[TBL] [Abstract][Full Text] [Related]
3. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
4. HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma.
Lauret E; Rodríguez M; González S; Linares A; López-Vázquez A; Martínez-Borra J; Rodrigo L; López-Larrea C
Am J Gastroenterol; 2002 Apr; 97(4):1016-21. PubMed ID: 12003382
[TBL] [Abstract][Full Text] [Related]
5. Iron, HFE mutations, and hepatocellular carcinoma: is hepatic iron a carcinogen?
Ioannou GN; Kowdley KV
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):246-8. PubMed ID: 15017663
[No Abstract] [Full Text] [Related]
6. Semiquantitative and qualitative assessment of hepatic iron in patients with chronic viral hepatitis: relation with grading, staging and haemochromatosis mutations.
Vergani A; Bovo G; Trombini P; Caronni N; Arosio C; Malosio I; Fossati L; Roffi L; Piperno A
Ital J Gastroenterol Hepatol; 1999; 31(5):395-400. PubMed ID: 10470600
[TBL] [Abstract][Full Text] [Related]
7. Increased hepatic iron and cirrhosis: no evidence for an adverse effect on patient outcome following liver transplantation.
Stuart KA; Fletcher LM; Clouston AD; Lynch SV; Purdie DM; Kerlin P; Crawford DH
Hepatology; 2000 Dec; 32(6):1200-7. PubMed ID: 11093725
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis.
Sikorska K; Bernat A; Wroblewska A
Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):461-479. PubMed ID: 27733315
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.
Fargion S; Stazi MA; Fracanzani AL; Mattioli M; Sampietro M; Tavazzi D; Bertelli C; Patriarca V; Mariani C; Fiorelli G
Blood Cells Mol Dis; 2001; 27(2):505-11. PubMed ID: 11500061
[TBL] [Abstract][Full Text] [Related]
10. Dietary iron overload in the African and hepatocellular carcinoma.
Kew MC; Asare GA
Liver Int; 2007 Aug; 27(6):735-41. PubMed ID: 17617115
[TBL] [Abstract][Full Text] [Related]
11. The role of iron in the pathophysiology and treatment of chronic hepatitis C.
Price L; Kowdley KV
Can J Gastroenterol; 2009 Dec; 23(12):822-8. PubMed ID: 20011735
[TBL] [Abstract][Full Text] [Related]
12. Iron overload in nonalcoholic steatohepatitis.
Fujita N; Takei Y
Adv Clin Chem; 2011; 55():105-32. PubMed ID: 22126026
[TBL] [Abstract][Full Text] [Related]
13. Iron as a co-morbid factor in nonhemochromatotic liver disease.
Bonkovsky HL; Lambrecht RW; Shan Y
Alcohol; 2003 Jun; 30(2):137-44. PubMed ID: 12957298
[TBL] [Abstract][Full Text] [Related]
14. Hepatic iron overload in alcoholic end-stage liver disease is associated with iron deposition in other organs in the absence of HFE-1 hemochromatosis.
Eng SC; Taylor SL; Reyes V; Raaka S; Berger J; Kowdley KV
Liver Int; 2005 Jun; 25(3):513-7. PubMed ID: 15910487
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.
Ko C; Siddaiah N; Berger J; Gish R; Brandhagen D; Sterling RK; Cotler SJ; Fontana RJ; McCashland TM; Han SH; Gordon FD; Schilsky ML; Kowdley KV
Liver Int; 2007 Dec; 27(10):1394-401. PubMed ID: 17927713
[TBL] [Abstract][Full Text] [Related]
16. The role of iron overload and HFE gene mutations in the era of pegylated interferon and ribavirin treatment of chronic hepatitis C.
Sikorska K; Stalke P; Izycka-Swieszewska E; Romanowski T; Bielawski KP
Med Sci Monit; 2010 Mar; 16(3):CR137-143. PubMed ID: 20190684
[TBL] [Abstract][Full Text] [Related]
17. Pathology of hepatic iron overload.
Deugnier Y; Turlin B
World J Gastroenterol; 2007 Sep; 13(35):4755-60. PubMed ID: 17729397
[TBL] [Abstract][Full Text] [Related]
18. [Hereditary and acquired iron overload].
de Korwin JD
Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
[TBL] [Abstract][Full Text] [Related]
19. Iron, the HFE gene, and hepatitis C.
Eisenbach C; Gehrke SG; Stremmel W
Clin Liver Dis; 2004 Nov; 8(4):775-85, vii-viii. PubMed ID: 15464655
[TBL] [Abstract][Full Text] [Related]
20. Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.
Fracanzani AL; Fargion S; Stazi MA; Valenti L; Amoroso P; Cariani E; Sangiovanni A; Tommasini M; Rossini A; Bertelli C; Fatta E; Patriarca V; Brescianini S; Stroffolini T
Blood Cells Mol Dis; 2005; 35(1):27-32. PubMed ID: 15894495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
